Company We are GSK As a focused biopharma company, we discover, develop and deliver medicines and vaccines to create value for patients and shareholders. We aim to positively impact the health of …

Careers We are GSK At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, …

Sep 17, 2025 · GSK plc (LSE/NYSE: GSK) today announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years.

GSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs.

Apr 12, 2026 · Promising efficacy and safety profile supports start of five pivotal phase III trials in 2026 GSK plc (LSE/NYSE: GSK) today announced positive findings from its global phase I BEHOLD-1 …

Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more product information on …

Locations - GSK US ... tbc

The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta, PA site dedicated to smallpox vaccine production since 1882. Today, our …

Mar 13, 2026 · GSK continues to advance regulatory submissions for its RSV vaccine across multiple geographies to expand availability and support long-term growth objectives. About AREXVY …

Life at GSK We are transforming our culture to create an environment where individuals and teams are inspired to be ambitious for patients